Recent ESPR Stock Price | ESPR Stock Predictions | |
$2.08 | +270.19% |
$7.70 |
Recent ESPR Analyst Ratings Breakdown, Making ESPR Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 4 | 4 | 4 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.88 | 1.88 | 1.88 | 1.88 |
For the ESPR stock predictions from the analysts covering Esperion Therapeutics Inc (New), we have collected all of the individual ESPR stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 7 different analysts covering ESPR (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ESPR stock predictions may vary widely, another useful metric to consider is the median ESPR stock prediction, which represents the price at which half of the analysts
made ESPR stock predictions that were higher and half made ESPR stock predictions that were lower. This makes for a different take on the ESPR stock predictions out there, as compared to average or mean.
And that median across all the individual ESPR stock predictions was: $8.0 as of 2024-04-24.
The very highest of the ESPR stock predictions for one year price target was $16.0, while the very lowest of the ESPR stock predictions in the analyst group was
$2.9 (with a standard deviation of $4.625). Get the latest Zacks research report on ESPR — FREE
Find out: ESPR next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CZZ Stock Predictions
DRQ Stock Predictions
IAA Stock Predictions
CTRE Stock Predictions
RGNX Stock Predictions
CATY Stock Predictions
MCB Stock Predictions
MOMO Stock Predictions
T Stock Predictions
|
|
Buy (3.12 out of 4) 40th percentile
(ranked lower than approx. 60% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |